II
TARO

Inspire Investing’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Inspire Investing’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,008
Closed -$62K – 750
2020
Q1 		$62K Buy
+1,008
New +$74.7K 0.02% 537
2018
Q1 		– Sell
-4
Closed – – 748
2017
Q4 		$0 Buy
+4
New +$440 ﹤0.01% 929

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Inspire Investing's TARO Position: Q2 2020 in Review

Inspire Investing sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2020, closing a stake of 1,008 shares — an estimated $62K sold.

Inspire Investing first reported a position in TARO in Q4 2017 and held it in 2 quarters. The position peaked at $62K in Q1 2020. 84 funds tracked by Wall St. Rank hold TARO as of Q2 2020.

  • Inspire Investing reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2020 after selling out during the quarter.
  • Inspire Investing sold 1,008 Taro Pharmaceutical Industries Ltd. shares in Q2 2020, an estimated $62K.
  • Inspire Investing first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 2 quarters.
  • Inspire Investing's Taro Pharmaceutical Industries Ltd. position peaked at $62K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.